Clinical Trial Update: A Single-arm Clinical Study Evaluating Pirfenidone and Sintilimab in Combination With Standard Neoadjuvant Chemotherapy for Colorectal Cancer Patients With Peritoneal Metastasis. [Phase 2]

View source ↗

Summary

This Phase 2, single-arm trial evaluates pirfenidone with sintilimab plus standard neoadjuvant chemotherapy for colorectal cancer with peritoneal metastasis; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Esbriet (pirfenidone)
• Tyvyt (Sintilimab)

Snippet

Sponsor: Guoxiang Cai | Conditions: Colorectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING